HighTower Advisors, LLC

Position in CUE — Cue Biopharma, Inc.

CIK 1462245 CHICAGO, IL

Position in CUE

as of Dec 31, 2025 · filed Feb 6, 2026 Compact

Position Value

$3,333

-$113,533 QoQ

Shares Held

10,929

-91.5% QoQ

Ownership

0.270%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

HighTower Advisors, LLC holds $268,759,923 across 111 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)
1	INBX	Inhibrx Biosciences, Inc.	870,200	$58,503,546
2	REGN	Regeneron Pharmaceuticals, Inc.	58,925	$45,527,812
3	ALNY	Alnylam Pharmaceuticals, Inc.	105,859	$35,025,567
4	VRTX	Vertex Pharmaceuticals Inc / Ma	65,684	$29,330,533
5	RPRX	Royalty Pharma plc	292,921	$14,051,420
6	AXSM	Axsome Therapeutics, Inc.	56,633	$9,572,109
7	ARWR	Arrowhead Pharmaceuticals, Inc.	146,462	$9,183,167
8	MDGL	Madrigal Pharmaceuticals, Inc.	13,914	$7,283,561

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2025-12-31	$3,333	10,929	-91.5%	Shares	Sole	2026-02-06
2025-03-31	$116,866	128,284	0.0%	Shares	Sole	2025-05-13
2024-12-31	$139,829	128,284	+54.0%	Shares	Sole	2025-02-07
2024-09-30	$63,045	83,284	0.0%	Shares	Sole	2024-11-14
2024-06-30	$103,272	83,284	+7.5%	Shares	Sole	2024-08-13
2024-03-31	$146,475	77,500	-0.8%	Shares	Sole	2024-05-06
2023-12-31	$206,210	78,110	0.0%	Shares	Sole	2024-02-12
2023-09-30	$179,653	78,110	+2.6%	Shares	Sole	2023-11-08
2023-06-30	$277,801	76,110	0.0%	Shares	Sole	2023-08-14
2023-03-31	$271,712	76,110	—	Shares	Sole	2023-05-12
No filing history on record for this holder in this stock.